taurolidine has been researched along with Sepsis in 18 studies
*Sepsis: Systemic inflammatory response syndrome with a proven or suspected infectious etiology. When sepsis is associated with organ dysfunction distant from the site of infection, it is called severe sepsis. When sepsis is accompanied by HYPOTENSION despite adequate fluid infusion, it is called SEPTIC SHOCK. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (5.56) | 18.7374 |
| 1990's | 1 (5.56) | 18.2507 |
| 2000's | 6 (33.33) | 29.6817 |
| 2010's | 2 (11.11) | 24.3611 |
| 2020's | 8 (44.44) | 2.80 |
| Authors | Studies |
|---|---|
| Fiocco, MF; Frakking, FNJ; Jeremiasse, B; Loeffen, YGT; van de Ven, CP; van de Wetering, MD; van den Bosch, CH; van der Bruggen, JT; van der Steeg, AFW; Wijnen, MHWA | 1 |
| Day, AS; Frampton, CM; Lopez, RN; Vernon-Roberts, A | 1 |
| Bai, Z; Hassan, F; Huang, J; Ita, M; Li, Y; O'Leary, DP; Redmond, HP; Wang, J; Wang, JH; Zhao, H; Zhou, H | 1 |
| Fiocco, M; Frakking, FNJ; Loeffen, Y; van de Ven, CP; van de Wetering, MD; van den Bosch, CH; van der Bruggen, JT; van der Steeg, AFW; Wijnen, MHWA | 1 |
| Blaha, V; Machacova, A; Marikova, M; Ryskova, L; Visek, J | 1 |
| Agarwal, AK; Hurlburt, E; Mounts, P; Pfaffle, A; Poggio, EC; Roy-Chaudhury, P | 1 |
| D'Eusebio, C; Hill, S; King, E; Koeglmeier, J; Littlechild, H; Puoti, MG | 1 |
| Bottos, P; Brescia, F; Da Ros, V; Fabiani, F; Moreal, C; Nadalini, E; Pittiruti, M; Scoppettuolo, G; Zanier, C | 1 |
| Galas, A; Hermanowicz, A; Klek, S; Szczepanek, K | 1 |
| Bradshaw, JH; Puntis, JW | 1 |
| Cahill, J; Gerrish, M; Little, J; Taylor, C | 1 |
| Brind, J; Chu, HP; Hill, S; Tomar, R | 1 |
| Feinstein, D; Kumar, A; Manocha, S | 1 |
| Betjes, MG; van Agteren, M | 1 |
| Reinmüller, J | 1 |
| Feldmer, B; Polaschegg, HD; Sodemann, K | 1 |
| Forneris, G; Quarello, F | 1 |
| Brodhage, H; Browne, MK; Leslie, GB; Pfirrman, RW | 1 |
5 review(s) available for taurolidine and Sepsis
| Article | Year |
|---|---|
The efficacy of taurolidine containing lock solutions for the prevention of central-venous-catheter-related bloodstream infections: a systematic review and meta-analysis.
Topics: Catheter-Related Infections; Catheterization, Central Venous; Central Venous Catheters; Humans; Randomized Controlled Trials as Topic; Sepsis; Taurine; Thiadiazines | 2022 |
Meta-analysis of the efficacy of taurolidine in reducing catheter-related bloodstream infections for patients receiving parenteral nutrition.
Topics: Catheter-Related Infections; Catheterization, Central Venous; Central Venous Catheters; Humans; Parenteral Nutrition, Home; Sepsis; Taurine; Thiadiazines | 2022 |
Taurolidine and catheter-related bloodstream infection: a systematic review of the literature.
Topics: Anti-Infective Agents; Catheterization, Central Venous; Equipment Contamination; Evidence-Based Medicine; Humans; Sepsis; Taurine; Thiadiazines | 2008 |
Novel therapies for sepsis: antiendotoxin therapies.
Topics: Acute-Phase Proteins; Antibodies, Monoclonal; Carrier Proteins; Endotoxins; Humans; Lipopolysaccharide Receptors; Membrane Glycoproteins; Polymyxin B; Sepsis; Signal Transduction; Taurine; Thiadiazines; Vaccination | 2002 |
Prevention of hemodialysis catheter-related bloodstream infection using an antimicrobial lock.
Topics: Anti-Infective Agents, Local; Catheters, Indwelling; Citric Acid; Equipment Contamination; Equipment Design; Humans; Infection Control; Renal Dialysis; Sepsis; Taurine; Thiadiazines | 2002 |
5 trial(s) available for taurolidine and Sepsis
| Article | Year |
|---|---|
CATERPILLAR-study protocol: an assessor-blinded randomised controlled trial comparing taurolidine-citrate-heparin to heparin-only lock solutions for the prevention of central line-associated bloodstream infections in paediatric oncology patients.
Topics: Catheter-Related Infections; Central Venous Catheters; Child; Citrates; Citric Acid; Heparin; Humans; Neoplasms; Quality of Life; Randomized Controlled Trials as Topic; Sepsis | 2023 |
Taurolidine/Heparin Lock Solution and Catheter-Related Bloodstream Infection in Hemodialysis: A Randomized, Double-Blind, Active-Control, Phase 3 Study.
Topics: Adult; Catheter-Related Infections; Catheterization, Central Venous; Central Venous Catheters; Heparin; Humans; Renal Dialysis; Sepsis | 2023 |
Taurolidine lock in home parenteral nutrition in adults: results from an open-label randomized controlled clinical trial.
Topics: Adult; Anti-Infective Agents; Bacteremia; Catheter-Related Infections; Catheterization, Central Venous; Central Venous Catheters; Female; Fungemia; Humans; Male; Middle Aged; Parenteral Nutrition, Home; Retrospective Studies; Sepsis; Taurine; Thiadiazines | 2015 |
A new haemodialysis catheter-locking agent reduces infections in haemodialysis patients.
Topics: Adult; Aged; Aged, 80 and over; Anti-Infective Agents, Local; Catheters, Indwelling; Chi-Square Distribution; Cost of Illness; Cross Infection; Cross-Over Studies; England; Equipment Contamination; Equipment Design; Female; Humans; Incidence; Infection Control; Kidney Failure, Chronic; Logistic Models; Male; Middle Aged; Multivariate Analysis; Prospective Studies; Renal Dialysis; Sepsis; Taurine; Therapeutic Irrigation; Thiadiazines | 2008 |
Prevention of dialysis catheter-related sepsis with a citrate-taurolidine-containing lock solution.
Topics: Anti-Infective Agents; Bacterial Infections; Catheterization, Central Venous; Catheters, Indwelling; Citric Acid; Equipment Contamination; Female; Humans; Male; Middle Aged; Prospective Studies; Renal Dialysis; Sepsis; Solutions; Taurine; Thiadiazines | 2004 |
8 other study(ies) available for taurolidine and Sepsis
| Article | Year |
|---|---|
Autophagy induced by taurolidine protects against polymicrobial sepsis by promoting both host resistance and disease tolerance.
Topics: Animals; Autophagy; Mice; Phagocytosis; Sepsis; Taurine; Thiadiazines | 2022 |
In vitro comparison of the effectiveness of various antimicrobial locks with taurolidine in the treatment and prevention of catheter-related bloodstream infections in patients receiving parenteral nutrition.
Topics: Anti-Infective Agents; Catheter-Related Infections; Catheters; Humans; Methicillin-Resistant Staphylococcus aureus; Parenteral Nutrition; Sepsis; Staphylococcus aureus | 2023 |
Risk factors for catheter-related bloodstream infections associated with home parental nutrition in children with intestinal failure: A prospective cohort study.
Topics: Catheter-Related Infections; Catheters; Central Venous Catheters; Child; Graft vs Host Disease; Humans; Intestinal Diseases; Intestinal Failure; Male; Parenteral Nutrition, Home; Prospective Studies; Retrospective Studies; Risk Factors; Sepsis | 2023 |
Taurolidine lock in the treatment of colonization and infection of totally implanted venous access devices in cancer patients.
Topics: Catheter-Related Infections; Catheterization, Central Venous; Central Venous Catheters; Humans; Neoplasms; Retrospective Studies; Sepsis; Taurine; Thiadiazines | 2023 |
Significant reduction in central venous catheter-related bloodstream infections in children on HPN after starting treatment with taurolidine line lock.
Topics: Adolescent; Adult; Anti-Infective Agents; Anticoagulants; Catheter-Related Infections; Catheterization, Central Venous; Central Venous Catheters; Child; Child, Preschool; Gastrointestinal Diseases; Gastrointestinal Motility; Heparin; Humans; Infant; Infant, Newborn; Parenteral Nutrition, Home; Sepsis; Short Bowel Syndrome; Taurine; Thiadiazines; Young Adult | 2012 |
[The influence of taurolidine on physiological and pathological blood coagulation and implications for its use].
Topics: Anti-Infective Agents, Local; Bacterial Infections; Blood Coagulation; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Sepsis; Staphylococcal Infections; Taurine; Thiadiazines | 1999 |
Two years' experience with Dialock and CLS (a new antimicrobial lock solution).
Topics: Adult; Anti-Infective Agents; Anticoagulants; Catheterization, Central Venous; Catheters, Indwelling; Citric Acid; Equipment Design; Femoral Vein; Heart Atria; Humans; Incidence; Infection Control; Jugular Veins; Kidney Failure, Chronic; Pilot Projects; Renal Dialysis; Retrospective Studies; Risk Assessment; Safety; Sepsis; Solutions; Subclavian Vein; Taurine; Thiadiazines | 2001 |
The in vitro and in vivo activity of taurolin against anaerobic pathogenic organisms.
Topics: Animals; Bacterial Infections; Bacteroides; Bacteroides Infections; Clostridium Infections; Clostridium perfringens; Male; Mice; Peptostreptococcus; Peritonitis; Rabbits; Sepsis; Taurine; Thiadiazines; Thiazines | 1977 |